MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 139110-80-8
Formula C12H20N4O7MW 332.31Research-use catalog entryCOA/SDS by request

Zanamivir

CAS Number: 139110-80-8

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
1 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
10 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
50 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: ARAIBEBZBOPLMB-UFGQHTETSA-NC12H20N4O7 | MW 332.31

Chemical Absolute Identifiers

CAS Number

139110-80-8

PubChem CID

60855

Molecular Formula

C12H20N4O7

Molecular Weight

332.31 g/mol

Exact Mass

332.133199

InChIKey

ARAIBEBZBOPLMB-UFGQHTETSA-N

IUPAC Name

(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid

SMILES String

CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N

Physical Properties

Melting Point

256.0 °C

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Zanamivir (CAS 139110-80-8) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C12H20N4O7 and molecular weight 332. 31 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Neuraminidase (Influenza A virus) — 132 assays; Neuraminidase (Influenza B virus (strain B/Lee/1940)) — 13 assays; Neuraminidase (Influenza A virus) — 7 assays; Neuraminidase (Influenza A virus (A/Puerto Rico/8/1934(H1N1))) — 26 assays; Neuraminidase (Influenza A virus) — 4 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Neuraminidase

Influenza A virus · SINGLE PROTEIN · 132 qualifying assays · 24 documents · best pChEMBL 10.52

Experimental evidence source: ChEMBL

Neuraminidase

Influenza B virus (strain B/Lee/1940) · SINGLE PROTEIN · 13 qualifying assays · 10 documents · best pChEMBL 10

Experimental evidence source: ChEMBL

Neuraminidase

Influenza A virus · SINGLE PROTEIN · 7 qualifying assays · 4 documents · best pChEMBL 9.4

Experimental evidence source: ChEMBL

Neuraminidase

Influenza A virus (A/Puerto Rico/8/1934(H1N1)) · SINGLE PROTEIN · 26 qualifying assays · 22 documents · best pChEMBL 9.3

Experimental evidence source: ChEMBL

Neuraminidase

Influenza A virus · SINGLE PROTEIN · 4 qualifying assays · 2 documents · best pChEMBL 9.3

Experimental evidence source: ChEMBL

Safety & Handling

PPE

Respiratory protection if needed

First Aid

  • Do not give anything to an unconscious person.
  • Rinse mouth with water.

Stability / Reactivity

  • Reactivity and stability.
  • Carbon monoxide, carbon dioxide, nitrogen oxides.

Disposal

  • Waste: Dispose of remaining and non-recyclable solutions to a licensed company.
  • Contact a professional institution with a waste disposal license to handle this substance.
Show additional safety reference fields

Fire Fighting

  • If necessary, wear a self-contained breathing apparatus for firefighting.

Accidental Release

  • Do not generate dust when collecting and disposing.
  • Sweep and shovel up.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Zanamivir

Names & Synonyms

RelenzaGANA4-Guanidino-Neu5Ac2enGG167GR 121167X
Show all synonyms
GANA (inhibitor)GG 1674-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid4-guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid(2r,3r,4s)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid4 Guanidino Neu5Ac2enzanamivirum(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid(2R,3R,4S)-4-((diaminomethylidene)amino)-3-acetamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid4-guanidino-2-deoxy-2,3-didehydro-N-acetylneuraminic acidAcid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic
External Identifiers
EC NUMBER: 112-326-1EC NUMBER: 691-117-1DSSTOX SUBSTANCE ID: DTXSID0023749CHEMBL ID: CHEMBL222813CHEMBL ID: CHEMBL57705CHEBI ID: CHEBI:50663UNII: L6O3XI777IDRUGBANK ID: DB00558HMDB ID: HMDB0014698KEGG ID: C08095KEGG ID: D00902METABOLOMICS WORKBENCH ID: 42894NCI THESAURUS CODE: C47786PHARMGKB ID: PA164740891RXCUI: 69722WIKIDATA ID: Q146075
Literature & Patent References
DOI 10.1021/acs.jmedchem.4c02222Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles.PMID 39644238Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles.DOI 10.1016/j.ejmech.2022.114960Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcusaureus.DOI 10.1016/j.ejmech.2023.115275Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties.DOI 10.1016/j.ejmech.2023.115410Conformationally locked sugar derivatives and analogues as potential neuraminidase inhibitors.DOI 10.1016/j.ejmech.2023.115678Rational design and optimization of acylthioureas as novel potent influenza virus non-nucleoside polymerase inhibitors.DOI 10.1021/acs.jmedchem.2c00857Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PA<sub>N</sub> Endonuclease Inhibitors.DOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Laninamivir octanoate monohydrateCAS 1233643-88-3
Laninamivir octanoateCAS 203120-46-1
TamifluCAS 204255-11-8
PeramivirCAS 330600-85-6
Peramivir trihydrateCAS 1041434-82-5

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 1233643-88-3Laninamivir octanoate monohydrateCAS 203120-46-1Laninamivir octanoateCAS 100643-71-8DesloratadineCAS 112811-59-3GatifloxacinCAS 123318-82-1ClofarabineCAS 330600-85-6PeramivirCAS 130-95-0QuinineCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 139110-80-8

What are the key identifiers for Zanamivir (CAS 139110-80-8)?

Zanamivir is identified by CAS 139110-80-8, with molecular formula C12H20N4O7, molecular weight 332.31, InChIKey ARAIBEBZBOPLMB-UFGQHTETSA-N.

Does CAS 139110-80-8 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Neuraminidase, Neuraminidase, Neuraminidase, Neuraminidase, Neuraminidase. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 139110-80-8?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Zanamivir?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 139110-80-8 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.